Legal & General Group PLC Apellis Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

  • $368 Billion
  • Q4 2024

A detailed history of Legal & General Group PLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 86,771 shares of APLS stock, worth $2.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
86,771
Previous 97,650 11.14%
Holding current value
$2.11 Million
Previous $2.82 Million 1.7%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$26.18 - $35.42 $284,812 - $385,334
-10,879 Reduced 11.14%
86,771 $2.77 Million
Q3 2024

Feb 28, 2025
BUY
$28.84 - $41.15 $34,377 - $49,050
1,192 Added 1.37%
87,963 $2.54 Million
Q3 2024

Nov 14, 2024
SELL
$28.84 - $41.15 $106,938 - $152,584
-3,708 Reduced 3.66%
97,650 $2.82 Million
Q2 2024

Aug 14, 2024
BUY
$38.07 - $59.71 $590,617 - $926,340
15,514 Added 18.07%
101,358 $3.89 Million
Q1 2024

May 14, 2024
BUY
$55.39 - $72.47 $131,440 - $171,971
2,373 Added 2.84%
85,844 $5.05 Million
Q4 2023

Feb 15, 2024
BUY
$37.14 - $64.82 $62,878 - $109,740
1,693 Added 2.07%
83,471 $5 Million
Q3 2023

Nov 14, 2023
SELL
$23.65 - $89.22 $56,121 - $211,719
-2,373 Reduced 2.82%
81,778 $3.11 Million
Q2 2023

Aug 14, 2023
SELL
$76.68 - $93.31 $193,003 - $234,861
-2,517 Reduced 2.9%
84,151 $7.67 Million
Q1 2023

May 15, 2023
BUY
$46.59 - $66.96 $292,305 - $420,107
6,274 Added 7.8%
86,668 $5.72 Million
Q4 2022

Feb 14, 2023
SELL
$43.24 - $61.04 $10,723 - $15,137
-248 Reduced 0.31%
80,394 $4.16 Million
Q3 2022

Nov 14, 2022
SELL
$44.76 - $69.66 $59,620 - $92,787
-1,332 Reduced 1.62%
80,642 $5.51 Million
Q2 2022

Aug 22, 2022
BUY
$35.07 - $59.21 $407,408 - $687,842
11,617 Added 16.51%
81,974 $3.71 Million
Q1 2022

May 16, 2022
BUY
$35.46 - $54.12 $42,197 - $64,402
1,190 Added 1.72%
70,357 $3.58 Million
Q4 2021

Feb 14, 2022
BUY
$30.74 - $49.16 $346,378 - $553,934
11,268 Added 19.46%
69,167 $3.27 Million
Q3 2021

Nov 15, 2021
BUY
$31.4 - $69.84 $382,828 - $851,489
12,192 Added 26.67%
57,899 $1.91 Million
Q2 2021

Aug 12, 2021
BUY
$40.9 - $64.9 $24,949 - $39,589
610 Added 1.35%
45,707 $2.89 Million
Q1 2021

May 17, 2021
SELL
$40.8 - $57.39 $2,856 - $4,017
-70 Reduced 0.15%
45,097 $1.94 Million
Q4 2020

Feb 12, 2021
BUY
$30.79 - $57.2 $155,089 - $288,116
5,037 Added 12.55%
45,167 $2.58 Million
Q3 2020

Nov 13, 2020
BUY
$25.89 - $33.65 $501,929 - $652,372
19,387 Added 93.46%
40,130 $1.21 Million
Q2 2020

Aug 14, 2020
BUY
$24.8 - $38.49 $226,572 - $351,644
9,136 Added 78.71%
20,743 $678,000
Q1 2020

May 14, 2020
SELL
$17.91 - $44.33 $13,719 - $33,956
-766 Reduced 6.19%
11,607 $329,000
Q4 2019

Feb 13, 2020
BUY
$22.1 - $30.8 $41,923 - $58,427
1,897 Added 18.11%
12,373 $379,000
Q2 2019

Aug 14, 2019
BUY
$18.0 - $25.34 $40,446 - $56,938
2,247 Added 27.31%
10,476 $265,000
Q1 2019

May 15, 2019
BUY
$12.81 - $19.82 $22,468 - $34,764
1,754 Added 27.09%
8,229 $161,000
Q4 2018

Feb 15, 2019
BUY
$11.47 - $18.71 $5,012 - $8,176
437 Added 7.24%
6,475 $86,000
Q3 2018

Nov 20, 2018
BUY
$16.57 - $21.03 $10,820 - $13,732
653 Added 12.13%
6,038 $108,000
Q2 2018

Aug 10, 2018
BUY
$19.63 - $30.0 $68,763 - $105,090
3,503 Added 186.13%
5,385 $118,000
Q4 2017

Feb 13, 2018
BUY
$12.71 - $21.7 $23,920 - $40,839
1,882
1,882 $41,000

Others Institutions Holding APLS

# of Institutions
299
Shares Held
111M
Call Options Held
2.63M
Put Options Held
845K
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $2.67B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email